SCHEMBL6552542

SCHEMBL6552542

CCCCCCCC(C(N)=O)(C(=O)OC)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN5A Q14524 3/20 0.46
▸ SCN9A Q15858 3/20 0.46
▸ KCNN4 O15554 1/20 0.45
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ NR1I2 O75469 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ HTR2B P41595 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ NAAA Q02083 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ POLB P06746 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10947074 0.87 KCNN4 (0.46) SCN5ASCN9AKCNN4GAAMAPT
SCHEMBL10946564 0.87 KCNN4 (0.46) SCN5ASCN9AKCNN4GAAMAPT
SCHEMBL10943740 0.87 KCNN4 (0.46) SCN5ASCN9AKCNN4GAAMAPT
SCHEMBL10945058 0.85 SRC (0.48) KCNN4GAANAAAALDH1A1POLB
SCHEMBL29129074 0.85 SCN5A (0.42) SCN5ASCN9AGAAMAPTKMT2A
SCHEMBL28080179 0.82 KCNN4 (0.50) KCNN4GAAMAPTKMT2AMEN1
SCHEMBL15945934 0.82 PIN1 (0.43) SCN5ASCN9AMAPTKMT2AMEN1
SCHEMBL6818662 0.81 HDAC3 (0.49) GAAMAPTKMT2ANAAAALDH1A1
SCHEMBL28551396 0.80 SCN5A (0.50) SCN5ASCN9AKCNN4GAAKMT2A
SCHEMBL7102239 0.79 GAA (0.45) SCN5ASCN9AGAANAAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482929-A1 USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOLE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE Aventis Pharma Deutschland GmbH (DE) 2004-12-08 — — EP disclosed
WO-2003072098-A1 USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOLE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-04 — — WO disclosed
Send feedback